Diaclone is a respected centre of excellence in Monoclonal Antibody and Immunoassay development, designed to advance research applications in the fields of Immunotherapy & Cancer, Vaccinology, Allergy, Autoimmune diseases, amongst others.
The extensive product portfolio of mAbs, ELISA, ELISpot and Multiplex kits are used by key research, pharmaceutical and manufacturing organizations worldwide; a good example being our murine and human IFN- ELISpot kits and cytokines markers dedicated to CAR-T cell response monitoring or our human IL-6 ELISA kits to monitor Covid-19 disease and Cytokine Release Storm.
Diaclone’s 'B-clone' monoclonal antibodies are used across the life sciences industry (for example the clones: B-A38 anti-hCD138/Syndecan, B-E8 anti-hIL-6, B-B1 anti-hIFN-, B-D48 anti-hPerforin, Isotype controls, exosomes and anti-CAM…)
When your work needs specific reagents or scientific support, turn to the decades of product development and manufacturing legacy at Diaclone, a mAbexperts brand. We have over 500 Monoclonal antibody clones and over 1 000 products (ELISA, ELISpot and Multiplex kits) and a custom development services if you do not find your products in our catalog.
Our expertise and know-how make us a trusted partner for custom product development & custom services (antibody development with hybridoma & phage display technologies), bioassays, cell based assays and analytical services.
We offer custom antibody development, immunoassay development and sample testing services.
• Monoclonal antibody development (Hybridoma technology)
• Recombinant antibody development (Phage Display technology)
• Hybridoma to recombinant antibody conversion, antibody sequencing and engineering
• ELISA development and optimization
• Analytical platform: antibody characterization & validation (specificity, affinity, bioactivity), samples testing, quality controls: ELISA, western blotting, octet, cytometry,
• Cell based assays
Contact us for more information.
DIACLONE s.a.s. has not received any reviews.
DIACLONE s.a.s. has not received any endorsements.